Logo

Aarti Drugs Share Price

Aarti Drugs (INR)429.95-12.3   (-2.8%)

Exchange ScripsBSE524348NSEAARTIDRUGSISININE767A01016

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Aarti Drugs Performance

Market performance
Open price440
High442.2
Volumes102306
Prev Close429.95
Low429
Closing date2025-01-10
Historical performance
1 Year High635.00
3 Year High645.75
5 Year High1026.95
1 Year Low419.55
3 Year Low313.90
5 Year Low105.25

Aarti Drugs Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
3924
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
23.06
Dividend Yield
Dividend Yield
0.02 %

Aarti Drugs Investment Returns

1 Year
-17.1%
3 Years
-18.7%
5 Years
196.3%
10 Years
242.8%

Aarti Drugs Technicals

IndicatorsValueSignal
5-DMA447.78Bearish
10-DMA452.56Bearish
20-DMA447.36Bearish
50-DMA458.82Bearish
100-DMA493.9Bearish
200-DMA497.71Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters4141414140
Foreign Investors---------------
Domestic Investors4141414140
Public Investors190240150177157506170373167406
Government---------------

Aarti Drugs Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income402211345
Operating Profit3249311634394449
Interest379371239262
Depreciation514503500499
Profit Before Tax2355224227003690
Consolidated Net Profit1714166320502804
Adjusted EPS19182230

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital919926926932
Total Reserves118961099894388202
Minority Interest42-1---
Total Non-Current Liabilities3549279323162572
Total Liabilities24324242142208017660
Capital Work in Progress22521868767193
Total Assets24324242142208017660

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities358913337041550
Cash Flow from Investing Activities-2237-1640-1496-718
Cash Flow from Financing Activitie-1360165920-811
Net Cash Inflow / Outflow-8-14112820
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 23.06.
  • 3Y Stock Price CAGR of the stock is -6.5.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹3249 Million.
  • The company generated revenue of ₹25286 Million in the previous financial year.

Aarti Drugs

429.95-12.3   (-2.8%)

Investment Amount: ₹ 53230
Current Value: ₹ 42995
Performance: -19.2%
P/L: ₹ -10235
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month